Abstract
In humans, age-related memory impairments begin in mid-life and cognitive weakening continues with advancing age. An important aspect of defining memory decline is the distinction between dementia as a result of neurological diseases, such as Alzheimer’s disease, and memory loss not specifically associated with disease. Within the population of elderly without dementia, there is considerable variability in memory. This variability is likely to be a result of the interaction of genetic make-up and environment, which influences several processes for cell maintenance and repair including oxidative damage and cholesterol metabolism, leading to disruption of Ca2+ homeostasis, and ultimately Ca2+-dependent processes that underlie memory. In humans, several methods have been employed to distinguish biological markers of aging that may predict cognitive decline.
Memory deficits associated with normal aging and Alzheimer’s disease have been linked to a decrease in the volume of brain structures, such as the hippocampus and to genetic markers, such as apolipoprotein E. In this regard, examination of CSF for biomarkers of disease can help in differentiating normal aging from Alzheimer’s disease. Measures of oxidative stress and cholesterol in plasma correlate with memory deficits; research suggests that treatments that reduce oxidative stress or cholesterol through exercise, diet or the use of antioxidant vitamins may delay cognitive decline.
Nevertheless, to date, very little treatment is available to reverse memory deficits in later life. In this regard it is important to identify individuals at risk for memory deficits in order to discriminate different mechanisms of brain aging and develop treatments.
Considerable effort is driving research to develop accurate biological markers of brain aging. In turn, these markers will provide information on mechanisms of aging and cognitive decline and point to potential treatments. Accordingly, the effectiveness of treatment needs to be verified for both cognitive changes and biological markers that are specific for age-related memory deficits.
Similar content being viewed by others
References
Larrabee GJ, Crook III TH. Estimated prevalence of age-associated memory impairment derived from standardized tests of memory function. Int Psychogeriatr 1994; 6(1): 95–104
Kral VA, Senescent forgetfulness: benign and malignant. CMAJ 1962. 86: 257–60
Crook T, Bartus RT, Ferris SH, et al. Age-associated memory impairment: proposed diagnostic criteria and measures of clinical change. Dev Neuropsychol 1986; 2: 261–76
Verhaeghen P, Salthouse TA. Meta-analyses of age-cognition relations in adulthood: estimates of linear and nonlinear age effects and structural models. Psychol Bull 1997; 122(3): 231–49
Park DC, Lautenschlager G, Hedden T, et al. Models of visuospatial and verbal memory across the adult life span. Psychol Aging 2002; 17(2): 299–320
Zelinski EM, Gilewski MJ, Schaie KW. Individual differences in cross-sectional and 3-year longitudinal memory performance across the adult life span. Psychol Aging 1993; 8(2): 176–86
Small SA, Stern Y, Tang M, et al. Selective decline in memory function among healthy elderly. Neurology 1999; 52(7): 1392–6
Levy R. Aging-associated cognitive decline. Working Party of the International Psychogeriatric Association in collaboration with the World Health Organization. Int Psychogeriatr 1994; 6(1): 63–8
Petersen RC, Smith GE, Waring SC, et al. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999; 56(3): 303–8
Jack Jr CR, Petersen RC, Xu Y, et al. Rates of hippocampal atrophy correlate with change in clinical status in aging and AD. Neurology 2000; 55(4): 484–9
Rusinek H, De Santi S, Frid D, et al. Regional brain atrophy rate predicts future cognitive decline: 6-year longitudinal MR imaging study of normal aging. Radiology 2003; 229(3): 691–6
Khachaturian ZS. Hypothesis on the regulation of cytosol calcium concentration and the aging brain. Neurobiol Aging 1987; 8(4): 345–6
Khachaturian ZS. Calcium hypothesis of Alzheimer’s disease and brain aging. Ann N Y Acad Sci 1994; 747: 1–11
Foster TC, Kumar A. Calcium dysregulation in the aging brain. Neuroscientist 2002; 8(4): 297–301
Gallagher M, Landfield PW, McEwen B, et al. Hippocampal neurodegeneration in aging. Science 1996; 274(5287): 484–5
Foster TC. Regulation of synaptic plasticity in memory and memory decline with aging. Prog Brain Res 2002; 138: 283–303
Erraji-Benchekroun L, Underwood MD, Arango V, et al. Molecular aging in human prefrontal cortex is selective and continuous throughout adult life. Biol Psychiatry 2005; 57(5): 549–58
Lu T, Pan Y, Kao SY, et al. Gene regulation and DNA damage in the ageing human brain. Nature 2004; 429(6994): 883–91
Foster TC. Involvement of hippocampal synaptic plasticity in age-related memory decline. Brain Res Brain Res Rev 1999; 30(3): 236–49
Toescu EC, Verkhratsky A. Ca2+ and mitochondria as substrates for deficits in synaptic plasticity in normal brain ageing. J Cell Mol Med 2004; 8(2): 181–90
Clayton DA, Grosshans DR, Browning MD. Aging and surface expression of hippocampal NMDA receptors. J Biol Chem 2002; 277(17): 14367–9
Sonntag WE, Lynch C, Thornton P, et al. The effects of growth hormone and IGF-1 deficiency on cerebrovascular and brain ageing. J Anat 2000; 197 Pt 4: 575–85
Mesches MH, Gemma C, Veng LM, et al. Sulindac improves memory and increases NMDA receptor subunits in aged Fischer 344 rats. Neurobiol Aging 2004; 25(3): 315–24
Norris CM, Ilalpain S, Foster TC. Alterations in the balance of protein kinase/phosphase activities in parallel reduced synaptic strength during aging. J Neurophysiol 1998; 80(3): 1567–70
Starkov AA, Chinopoulos C, Fiskum G. Mitochondrial calcium and oxidative stress as mediators of ischemic brain injury. Cell Calcium 2004; 36(3–4): 257–64
Lockhart BP, Lestage PJ. Cognition enhancing or neuroprotective compounds for the treatment of cognitive disorders: why? when? which? Exp Gerontol 2003; 38(1-2): 119–28
Lopez A, Birks J. Nimodipine for primary degenerative, mixed and vascular dementia. Cochrane Database Syst Rev 2001; (1): CD000147
Koch HJ, Szecsey A, Haen E. NMDA-antagonism (memantine): an alternative pharmacological therapeutic principle in Alzheimer’s and vascular dementia. Curr Pharm Des 2004; 10(3): 253–9
Saar D, Barkai E. Long-term modifications in intrinsic neuronal properties and rule learning in rats. Eur J Neurosci 2003; 17(12): 2727–34
Zeng H, Chattarji S, Barbarosie M, et al. Forebrain-specific calcineurin knockout selectively impairs bidirectional synaptic plasticity and working/episodic-like memory. Cell 2001; 107(5): 617–29
Winblad B, Engedal K, Soininen H, et al. A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD. Neurology 2001; 57(3): 489–95
Grantham C, Geerts H. The rationale behind cholinergic drug treatment for dementia related to cerebrovascular disease. J Neurol Sci 2002; 203-204: 131–6
Hedden T, Gabrieli JD. Insights into the ageing mind: a view from cognitive neuroscience. Nat Rev Neurosci 2004; 5(2): 87–96
Convit A, Wolf OT, Tarshish C, et al. Reduced glucose tolerance is associated with poor memory performance and hippocampal atrophy among normal elderly. Proc Natl Acad Sci U S A 2003; 100(4): 2019–22
Raz N, Gunning-Dixon FM, Head D, et al. Neuroanatomical correlates of cognitive aging: evidence from structural magnetic resonance imaging. Neuropsychology 1998; 12(1): 95–114
Lye TC, Piguet O, Grayson DA, et al. Hippocampal size and memory function in the ninth and tenth decades of life: the Sydney Older Persons Study. J Neurol Neurosurg Psychiatry 2004; 75(4): 548–54
de Leon MJ, DeSanti S, Zinkowski R, et al. MRI and CSF studies in the early diagnosis of Alzheimer’s disease. J Intern Med 2004; 256(3): 205–23
Takuma K, Yan SS, Stern DM, et al. Mitochondrial dysfunction, endoplasmic reticulum stress, and apoptosis in Alzheimer’s disease. J Pharmacol Sci 2005; 97(3): 312–6
Ankarcrona M, Winblad B. Biomarkers for apoptosis in Alzheimer’s disease. Int J Geriatr Psychiatry 2005; 20(2): 101–5
Rosen AC, Prall MW, Gabrieli JD, et al. Differential associations between entorhinal and hippocampal volumes and memory performance in older adults. Behav Neurosci 2003; 117(6): 1150–60
Grandman M, Jack Jr CR, Petersen RC, et al. Hippocampal volume is associated with memory but not monmemory cognitive performance in patients with mild cognitive impairment. J Mol Neurosci 2003; 20(3): 241–8
Golomb J, Kluger A, de Leon MJ, et al. Hippocampal formation size in normal human aging: a correlate of delayed secondary memory performance. Learn Mem 1994; 1(1): 45–54
Morrison JH, Hof PR. Life and death of neurons in the aging brain. Science 1997; 278(5337): 412–9
Lupien SJ, de Leon M, de Santi S, et al. Cortisol levels during human aging predict hippocampal atrophy and memory deficits. Nat Neurosci 1998; 1(1): 69–73
Eberling JL, Wu C, Haan MN, et al. Preliminary evidence that estrogen protects against age-related hippocampal atrophy. Neurobiol Aging 2003; 24(5): 725–32
Colcombe SJ, Erickson Kl, Raz N, et al. Aerobic fitness reduces brain tissue loss in aging humans. J Gerontol A Biol Sci Med Sci 2003; 58(2): 176–80
Small GW. Brain-imaging surrogate markers for detection and prevention of age-related memory loss. J Mol Neurosci 2002; 19(1–2): 17–21
Andreasen N, Blennow K. CSF biomarkers for mild cognitive impairment and early Alzheimer’s disease. Clin Neurol Neurosurg 2005; 107(3): 165–73
Celsis P. Age-related cognitive decline, mild cognitive impairment or preclinical Alzheimer’s disease? Ann Med 2000; 32(1): 6–14
Kapaki E, Paraskevas GP, Zalonis I, et al. CSF tau protein and beta-amyloid (1–42) in Alzheimer’s disease diagnosis: discrimination from normal ageing and other dementias in the Greek population. Eur J Neurol 2003; 10(2): 119–28
Hamet P, Tremblay J. Genes of aging. Metabolism 2003; 52(10 Suppl. 2): 5–9
Lee CK, Weindruch R, Proila TA. Gene-expression profile of the ageing brain in mice. Nat Genet 2000; 25(3): 294–7
Verbitsky M, Yonan AL, Malleret G, et al. Altered hippocampal transcript profile accompanies an age-related spatial memory deficit in mice. Learn Mem 2004; 11(3): 253–60
Blalock EM, Chen KC, Sharrow K, et al. Gene microarrays in hippocampal aging: statistical profiling identifies novel processes correlated with cognitive impairment. J Neurosci 2003; 23(9): 3807–19
Mayford M, Kandel ER. Genetic approaches to memory storage. Trends Genet 1999; 15(11): 463–70
Foster TC, Sharrow KM, Masse JR, et al. Calcineurin links Ca2+ dysregulation with brain aging. J Neurosci 2001; 21(11): 4066–73
Bartres-Faz D, Junque C, Lopez A, et al. Apo E influences declarative and procedural learning in age-associated memory impairment. Neuroreport 1999; 10(14): 2923–7
Deary IJ, Whiteman MC, Pattie A, et al. Cognitive change and the APOE epsilon 4 allele. Nature 2002; 418(6901): 932
Small BJ, Rosnick CB, Fratiglioni L, et al. Apolipoprotein E and cognitive performance: a meta-analysis. Psychol Aging 2004; 19(4): 592–600
Seeman TE, Huang MH, Bretsky P, et al. Education and APOEe4 in longitudinal cognitive decline: MacArthur studies of successful aging. J Gerontol B Psychol Sci Soc Sci 2005; 60(2): P74–83
Driscoll I, McDaniel MA, Guynn MJ. Apolipoprotein E and prospective memory in normally aging adults. Neuropsychology 2005; 19(1): 28–34
Kang JH, Logroscino G, De Vivo I, et al. Apolipoprotein E, cardiovascular disease and cognitive function in aging women. Neurobiol Aging 2005; 26(4): 475–84
Helbecque N, Amouyel P. Commonalities between genetics of cardiovascular disease and neurodegenerative disorders. Curr Opin Lipidol 2004; 15(2): 121–7
Cohen RM, Small C, Lalonde F, et al. Effect of apolipoprotein E genotype on hippocampal volume loss in aging healthy women. Neurology 2001; 57(12): 2223–8
Herz J, Bock HH. Lipoprotein receptors in the nervous system. Annu Rev Biochem 2002; 71: 405–34
Lahiri DK. Apolipoprotein E as a target for developing new therapeutics for Alzheimer’s disease based on studies from protein, RNA, and regulatory region of the gene. J Mol Neurosci 2004; 23(3): 225–34
Petanceska SS, DeRosa S, Sharma A, et al. Changes in apolipoprotein E expression in response to dietary and pharmacological modulation of cholesterol. J Mol Neurosci 2003; 20(3): 395–406
Ravaglia G, Forti P, Maioli F, et al. Blood homocysteine and vitamin B levels are not associated with cognitive skills in healthy normally ageing subjects. J Nutr Health Aging 2000; 4(4): 218–22
Cutler RG, Kelly J, Storie K, et al. Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer’s disease. Proc Natl Acad Sci U S A 2004; 101(7): 2070–5
Teunissen CE, De Vente J, von Bergmann K, et al. Serum cholesterol, precursors and metabolites and cognitive performance in an aging population. Neurobiol Aging 2003; 24(1): 147–55
Evans RM, Hui S, Perkins A, et al. Cholesterol and APOE genotype interact to influence Alzheimer disease progression. Neurology 2004; 62(10): 1869–71
Quan G, Xie C, Dietschy JM, et al. Ontogenesis and regulation of cholesterol metabolism in the central nervous system of the mouse. Brain Res Dev Brain Res 2003; 146(1–2): 87–98
Sparks DL, Scheff SW, Hunsaker III JC, et al. Induction of Alzheimer-like beta-amyloid immunoreactivity in the brains of rabbits with dietary cholesterol. Exp Neurol 1994; 126(1): 88–94
Refolo LM, Malester B, LaFrancois J, et al. Hypercholesterolemia accelerates the Alzheimer’s amyloid pathology in a transgenic mouse model. Neurobiol Dis 2000; 7(4): 321–31
Jick H, Zornberg GL, Jick SS, et al. Statins and the risk of dementia. Lancet 2000; 356(9242): 1627–31
Rockwood K, Kirkland S, Hogan DB, et al. Use of lipidlowering agents, indication bias, and the risk of dementia in community-dwelling elderly people. Arch Neurol 2002; 59(2): 223–7
Yaffe K, Barrett-Connor E, Lin F, et al. Serum lipoprotein levels, statin use, and cognitive function in older women. Arch Neurol 2002; 59(3): 378–84
Wolozin B, Kellman W, Ruosseau P, et al. Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors. Arch Neurol 2000; 57(10): 1439–43
Fassbender K, Simons M, Bergmann C, et al. Simvastatin strongly reduces levels of Alzheimer’s disease beta-amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo. Proc Natl Acad Sci U S A 2001; 98(10): 5856–61
Yehuda S, Rabinovitz S, Carasso RL, et al. The role of polyunsaturated fatty acids in restoring the aging neuronal membrane. Neurobiol Aging 2002; 23(5): 843–53
Young G, Conquer J. Omega-3 fatty acids and neuropsychiatrie disorders. Reprod Nutr Dev 2005; 45(1): 1–28
Solfrizzi V, Panza F, Capurso A. The role of diet in cognitive decline. J Neural Transm 2003; 110(1): 95–110
Morris MC, Evans DA, Bienias JL, et al. Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease. Arch Neurol 2003; 60(7): 940–6
Kawahara M, Kuroda Y. Intracellular calcium changes in neuronal cells induced by Alzheimer’s beta-amyloid protein are blocked by estradiol and cholesterol. Cell Mol Neurobiol 2001; 21(1): 1–13
Goritz C, Mauch DH, Nagler K, et al. Role of glia-derived cholesterol in synaptogenesis: new revelations in the synapseglia affair. J Physiol (Paris) 2002; 96(3-4): 257–63
Koudinov AR, Koudinova NV. Essential role for cholesterol in synaptic plasticity and neuronal degeneration. FASEB J 2001; 15(10): 1858–60
Starr JM, McGurn B, Whiteman M, et al. Life long changes in cognitive ability are associated with prescribed medications in old age. Int J Geriatr Psychiatry 2004; 19(4): 327–32
Etminan M, Gill S, Samii A. The role of lipid-lowering drugs in cognitive function: a meta-analysis of observational studies. Pharmacotherapy 2003; 23(6): 726–30
Wagstaff LR, Mitton MW, Arvik BM, et al. Statin-associated memory loss: analysis of 60 case reports and review of the literature. Pharmacotherapy 2003; 23(7): 871–80
King DS, Wilburn AJ, Wofford MR, et al. Cognitive impairment associated with atorvastatin and simvastatin. Pharmacotherapy 2003; 23(12): 1663–7
Berr C, Balansard B, Arnaud J, et al. Cognitive decline is associated with systemic oxidative stress: the EVA study. Etude du Vieillissement Arteriel. J Am Geriatr Soc 2000; 48(10): 1285–91
Perkins AJ, Hendrie HC, Callahan CM, et al. Association of antioxidants with memory in a multiethnic elderly sample using the Third National Health and Nutrition Examination Survey. Am J Epidemiol 1999; 150(1): 37–44
Perrig WJ, Perrig P, Stahelin HB. The relation between antioxidants and memory performance in the old and very old. J Am Geriatr Soc 1997; 45(6): 718–24
Rinaldi P, Polidori MC, Metastasio A, et al. Plasma antioxidants are similarly depleted in mild cognitive impairment and in Alzheimer’s disease. Neurobiol Aging 2003; 24(7): 915–9
Berlin D, Chong G, Chertkow H, et al. Evaluation of HFE (hemochromatosis) mutations as genetic modifiers in sporadic AD and MCI. Neurobiol Aging 2004; 25(4): 465–74
Mattson MP, Pedersen WA, Duan W, et al. Cellular and molecular mechanisms underlying perturbed energy metabolism and neuronal degeneration in Alzheimer’s and Parkinson’s diseases. Ann N Y Acad Sci 1999; 893: 154–75
Akaishi T, Nakazawa K, Sato K, et al. Hydrogen peroxide modulates whole cell Ca2+ currents through L-type channels in cultured rat dentate granule cells. Neurosci Lett 2004; 356(1): 25–8
Bindokas VP, Jordan J, Lee CC, et al. Superoxide production in rat hippocampal neurons: selective imaging with hydroethidine. J Neurosci 1996; 16(4): 1324–36
Sengpiel B, Preis E, Krieglstein J, et al. NMDA-induced superoxide production and neurotoxicity in cultured rat hippocampal neurons: role of mitochondria. Eur J Neurosci 1998; 10(5): 1903–10
Hongpaisan J, Winters CA, Andrews SB. Calcium-dependent mitochondrial Superoxide modulates nuclear CREB phosphorylation in hippocampal neurons. Mol Cell Neurosci 2003; 24(4): 1103–15
De Cabo R, Cabello R, Rios M, et al. Calorie restriction attenuates age-related alterations in the plasma membrane antioxidant system in rat liver. Exp Gerontol 2004; 39(3): 297–304
Wu A, Ying Z, Gomez-Pinilla F. The interplay between oxidative stress and brain-derived neurotrophic factor modulates the outcome of a saturated fat diet on synaptic plasticity and cognition. Eur J Neurosci 2004; 19(7): 1699–707
Beltowski J, Wojcicka G, Gorny D, et al. The effect of dietaryinduced obesity on lipid peroxidation, antioxidant enzymes and total plasma antioxidant capacity. J Physiol Pharmacol 2000; 51(4 Pt 2): 883–96
Liu R, Liu IY, Bi X, et al. Reversal of age-related learning deficits and brain oxidative stress in mice with Superoxide dismutase/catalase mimetics. Proc Natl Acad Sci U S A 2003; 100(14): 8526–31
Grodstein F, Chen J, Willett WC. High-dose antioxidant supplements and cognitive function in community-dwelling elderly women. Am J Clin Nutr 2003; 77(4): 975–84
Morris MC, Evans DA, Bienias JL, et al. Vitamin E and cognitive decline in older persons. Arch Neurol 2002; 59(7): 1125–32
Paleologos M, Cumming RG, Lazarus R. Cohort study of vitamin C intake and cognitive impairment. Am J Epidemiol 1998; 148(1): 45–50
Zandi PP, Anthony JC, Khachaturian AS, et al. Reduced risk of Alzheimer disease in users of antioxidant vitamin supplements: the Cache County Study. Arch Neurol 2004; 61(1): 82–8
Morris MC, Evans DA, Bienias JL, et al. Dietary intake of antioxidant nutrients and the risk of incident Alzheimer disease in a biracial community study. JAMA 2002; 287(24): 3230–7
Milgram NW, Head E, Muggenburg B, et al. Landmark discrimination learning in the dog: effects of age, an antioxidant fortified food, and cognitive strategy. Neurosci Biobehav Rev 2002; 26(6): 679–95
Bickford PC, Gould T, Briederick L, et al. Antioxidant-rich diets improve cerebellar physiology and motor learning in aged rats. Brain Res 2000; 866(1–2): 211–7
Socci DJ, Crandall BM, Arendash GW. Chronic antioxidant treatment improves the cognitive performance of aged rats. Brain Res 1995; 693(1–2): 88–94
Stoll S, Hartmann H, Cohen SA, et al. The potent free radical scavenger alpha-lipoic acid improves memory in aged mice: putative relationship to NMDA receptor deficits. Pharmacol Biochem Behav 1993; 46(4): 799–805
Cotman CW, Head E, Muggenburg BA, et al. Brain aging in the canine: a diet enriched in antioxidants reduces cognitive dysfunction. Neurobiol Aging 2002; 23(5): 809–18
Nagai T, Yamada K, Kim HC, et al. Cognition impairment in the genetic model of aging klotho gene mutant mice: a role of oxidative stress. FASEB J 2003; 17(1): 50–2
Sack CA, Socci DJ, Crandall BM, et al. Antioxidant treatment with phenyl-alpha-tert-butyl nitrone (PBN) improves the cognitive performance and survival of aging rats. Neurosci Lett 1996; 205(3): 181–4
Xie Z, Sastry BR. Impairment of long-term potentiation in rats fed with vitamin E-deficient diet. Brain Res 1995; 681(1–2): 193–6
Murray CA, Lynch MA. Dietary supplementation with vitamin E reverses the age-related deficit in long term potentiation in dentate gyms. J Biol Chem 1998; 273(20): 12161–8
McGahon BM, Martin DS, Horrobin DF, et al. Age-related changes in LTP and antioxidant defenses are reversed by an alpha-lipoic acid-enriched diet. Neurobiol Aging 1999; 20(6): 655–64
Petersen RC, Thomas RG, Grundman M, et al. Vitamin E and donepezil for the treatment of mild cognitive impairment. N Engl J Med 2005; 352(23): 2379–88
Luchsinger JA, Tang MX, Shea S, et al. Antioxidant vitamin intake and risk of Alzheimer’s disease. Arch Neurol 2003; 60(2): 203–8
Foster TC. Interaction of rapid signal transduction cascades and gene expression in mediating estrogen effects on memory over the life span. Front Neuroendocrinol 2005; 26(2): 51–64
Foster TC, Sharrow KM, Kumar A, et al. Interaction of age and chronic estradiol replacement on memory and markers of brain aging. Neurobiol Aging 2003; 24(6): 839–52
Wise PM, Dubai DB, Wilson ME, et al. Estrogens: trophic and protective factors in the adult brain. Front Neuroendocrinol 2001; 22(1): 33–66
Hibberd C, Yau JL, Seckl JR. Glucocorticoids and the ageing hippocampus. J Anat 2000; 197 Pt 4: 553–62
Pomara N, Greenberg WM, Branford MD, et al. Therapeutic implications of HPA axis abnormalities in Alzheimer’s disease: review and update. Psychopharmacol Bull 2003; 37(2): 120–34
Krabbe KS, Pedersen M, Bruunsgaard H. Inflammatory mediators in the elderly. Exp Gerontol 2004; 39(5): 687–99
Yaffe K, Lindquist K, Penninx BW, et al. Inflammatory markers and cognition in well-functioning African-American and white elders. Neurology 2003; 61(1): 76–80
Gasparini L, Ongini E, Wenk G. Non-steroidal anti-inflammatory drugs (NSAIDs) in Alzheimer’s disease: old and new mechanisms of action. J Neurochem 2004; 91(3): 521–36
Jain NK, Patil CS, Kulkarni SK, et al. Modulatory role of cyclooxygenase inhibitors in aging- and scopolamine or lipopolysaccharide-induced cognitive dysfunction in mice. Behav Brain Res 2002; 133(2): 369–76
Manly JJ, Touradji P, Tang MX, et al. Literacy and memory decline among ethnically diverse elders. J Clin Exp Neuropsychol 2003; 25(5): 680–90
Colcombe SJ, Kramer AF, McAuley E, et al. Neurocognitive aging and cardiovascular fitness: recent findings and future directions. J Mol Neurosci 2004; 24(1): 9–14
Fabre C, Chamari K, Mucci P, et al. Improvement of cognitive function by mental and/or individualized aerobic training in healthy elderly subjects. Int J Sports Med 2002; 23(6): 415–21
Hultsch DF, Hertzog C, Small BJ, et al. Use it or lose it: engaged lifestyle as a buffer of cognitive decline in aging? Psychol Aging 1999; 14(2): 245–63
Radak Z, Kaneko T, Tahara S, et al. Regular exercise improves cognitive function and decreases oxidative damage in rat brain. Neurochem Int 2001; 38(1): 17–23
Molteni R, Wu A, Vaynman S, et al. Exercise reverses the harmful effects of consumption of a high-fat diet on synaptic and behavioral plasticity associated to the action of brainderived neurotrophic factor. Neuroscience 2004; 123(2): 429–40
Devi SA, Kiran TR. Regional responses in antioxidant system to exercise training and dietary Vitamin E in aging rat brain. Neurobiol Aging 2004; 25(4): 501–8
Vaynman S, Ying Z, Gomez-Pinilla F. Interplay between brainderived neurotrophic factor and signal transduction modulators in the regulation of the effects of exercise on synaptic-plasticity. Neuroscience 2003; 122(3): 647–57
Schmidt-Hieber C, Jonas P, Bischofberger J. Enhanced synaptic plasticity in newly generated granule cells of the adult hippocampus. Nature 2004; 429(6988): 184–7
Tong L, Shen H, Perreau VM, et al. Effects of exercise on geneexpression profile in the rat hippocampus. Neurobiol Dis 2001; 8(6): 1046–56
Farmer J, Zhao X, van Praag H, et al. Effects of voluntary exercise on synaptic plasticity and gene expression in the dentate gyrus of adult male Sprague-Dawley rats in vivo. Neuroscience 2004; 124(1): 71–9
Churchill JD, Galvez R, Colcombe S, et al. Exercise, experience and the aging brain. Neurobiol Aging 2002; 23(5): 941–55
Swaab DF, Dubelaar EJ, Hofman MA, et al. Brain aging and Alzheimer’s disease; use it or lose it. Prog Brain Res 2002; 138: 343–73
Le Carret N, Lafont S, Mayo W, et al. The effect of education on cognitive performances and its implication for the constitution of the cognitive reserve. Dev Neuropsychol 2003; 23(3): 317–37
Whalley LJ, Deary IJ, Appleton CL, et al. Cognitive reserve and the neurobiology of cognitive aging. Ageing Res Rev 2004; 3(4): 369–82
Bennett DA, Wilson RS, Schneider JA, et al. Education modifies the relation of AD pathology to level of cognitive function in older persons. Neurology 2003; 60(12): 1909–15
Kubanis P, Zornetzer SF, Freund G. Memory and postsynaptic cholinergic receptors in aging mice. Pharmacol Biochem Behav 1982; 17(2): 313–22
Warren JM, Zerweck C, Anthony A. Effects of environmental enrichment on old mice. Dev Psychobiol 1982; 15(1): 13–8
Frick KM, Stearns NA, Pan JY, et al. Effects of environmental enrichment on spatial memory and neurochemistry in middleaged mice. Learn Mem 2003; 10(3): 187–98
Soffie M, Hahn K, Terao E, et al. Behavioural and glial changes in old rats following environmental enrichment. Behav Brain Res 1999; 101(1): 37–49
Acknowledgements
This work was supported by National Institutes of Health Grants AG14979, MH59891 and the Evelyn F. McKnight Brain Research Grant. The author has no conflicts of interest that are directly relevant to the content of this review.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Foster, T.C. Biological Markers of Age-Related Memory Deficits. CNS Drugs 20, 153–166 (2006). https://doi.org/10.2165/00023210-200620020-00006
Published:
Issue Date:
DOI: https://doi.org/10.2165/00023210-200620020-00006